VAERS reports by lot

Pfizer COVID-19 lot EWO178: VAERS reports

31 VAERS reports list lot EWO178 as a Pfizer COVID-19 vaccine, received between 2021-05-22 and 2023-05-29. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
31
Reports
16%
Marked serious
1
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological3321%
General / Systemic (non-local)2818%
Cardiac / Cardiovascular2314%
Musculoskeletal2113%
Respiratory1610%
Gastrointestinal128%
Injection-site / Local reaction106%
Psychiatric / Neuropsychiatric64%
Allergic / Anaphylactic43%
Dermatological (non-injection-site)43%
Thrombotic / Hematological11%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California6
New York4
Minnesota4
North Carolina2
Virginia2
Alabama1
Ohio1
New Jersey1
Indiana1
Connecticut1
Puerto Rico1
Michigan1

Reports by month received

2021-051
2021-0610
2021-074
2021-087
2021-091
2021-101
2021-112
2021-121
2022-011
2022-042
2023-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.